Latest Breaking News On - Kellym percival - Page 1 : vimarsana.com

New developments in treating gram-negative infections

New developments in treating gram-negative infections
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Kellym percivalUniversity of iowa hospitals clinicsClinical laboratory standards instituteLaboratory standards instituteIowa hospitals

Oral is the new IV : Another treatment dogma bites the dust?

Oral is the new IV : Another treatment dogma bites the dust?
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Boston city hospitalUnited statesMaxwell finlandEmilyg mcdonaldFrancisa waldvogelBrad spellbergRachaela leeKellym percivalLos angelesFabienne landryForum infectious diseasesUniversity of iowa hospitals clinicsUniversity of alabama at birminghamMcgill university health centerHarvard medical schoolInfectious disease

Inappropriate antibiotics for upper respiratory infections increase adverse events

Inappropriate antibiotics for upper respiratory infections increase adverse events
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Salt lake cityUnited statesKellym percivalUniversity of iowa hospitals clinicsAdobe stockCore elementsOutpatient antimicrobial stewardshipIowa hospitals

The changing landscape of OPAT to COpAT

Outpatient parenteral antimicrobial therapy programs are common for conditions that traditionally require weeks or months of parenteral treatment.

United statesUnited kingdomKellym percivalUniversity of iowa hospitals clinicsVirginia university medicineLos angeles countyWest virginia university medicineIowa hospitals

Linezolid dosing as part of three-drug regimen for drug-resistant TB

Infectious Disease News | In February, the CDC released provisional guidance for the use of pretomanid as part of the bedaquiline, pretomanid and linezolid (BPaL) regimen to treat drug-resistant tuberculosis.The guidance gives considerations for administration, precautions and adverse events, and microbiological monitoring. It recommends the use of BPaL in adults with pulmonary extensively drug resistant (XDR), pre-XDR or

United statesKellym percivalUniversity of iowa hospitals clinicsIowa hospitals